Please try another search
Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company’s Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers SNS-101, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company’s pipeline includes SNS-103 and SNS-102, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Name | Age | Since | Title |
---|---|---|---|
Thomas G. Ricks | 70 | 2015 | Independent Director |
William R. Ringo | 78 | 2022 | Independent Chairman |
John K. Celebi | 51 | 2018 | President, CEO & Director |
Robert Holmen | 59 | 2017 | Independent Director |
Alain Algazi | - | - | Member of Immuno-Oncology Advisory Board |
Kristian Humer | 49 | 2021 | Independent Director |
Richard J. Ulevitch | 80 | 2021 | Member of Immuno-Oncology Advisory Board |
Maura Gillison | - | 2021 | Member of Immuno-Oncology Advisory Board |
James Peyer | 37 | 2020 | Independent Director |
Sara Pai | - | - | Member of Immuno-Oncology Advisory Board |
Deneen Vojta | 59 | 2021 | Independent Director |
Jessie M. English | 60 | 2021 | Independent Director |
Robert Schreiber | - | - | Member of Immuno-Oncology Advisory Board |
Daniel H. Sterman | - | - | Member of Immuno-Oncology Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review